Solicitation of Nominations for Appointment to the Tick-Borne Disease Working Group; Extension of Nomination Period, 70185 [2020-24414]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
(PHS) Act, as amended. The Committee
is governed by the provisions of the
Federal Advisory Committee Act
(FACA), Public Law 92–463, as
amended (5 U.S.C. App.), which sets
forth standards for the formation and
use of advisory committees. The
ACBTSA advises, assists, consults with,
and makes policy recommendations to
the Secretary, through the Assistant
Secretary for Health, regarding broad
responsibilities related to the safety of
blood, blood products, tissues, and
organs. For solid organs and blood stem
cells, the Committee’s work is limited to
policy issues related to donor derived
infectious disease complications of
transplantation.
To carry out its mission, the ACBTSA
provides advice to the Secretary through
the Assistant Secretary for Health on a
range of policy issues which includes:
(1) Identification of public health issues
through surveillance of blood and tissue
safety issues with national biovigilance
data tools; (2) identification of public
health issues that affect availability of
blood, blood products, and tissues; (3)
broad public health, ethical, and legal
issues related to the safety of blood,
blood products, and tissues; (4) the
impact of various economic factors (e.g.,
product cost and supply) on safety and
availability of blood, blood products,
and tissues; (5) risk communications
related to blood transfusion and tissue
transplantation; and (6) identification of
infectious disease transmission issues
for blood, organs, blood stem cells and
tissues.
On October 9, 2020, the Secretary
approved for the ACBTSA charter to be
renewed. The new charter was effected
and filed with the appropriate
Congressional committees and the
Library of Congress on October 9, 2020.
Renewal of the Committee’s charter
gives authorization for the Committee to
continue to operate until October 9,
2022.
khammond on DSKJM1Z7X2PROD with NOTICES
A copy of the ACBTSA charter is
available on the Committee’s website at
https://www.hhs.gov/oidp/advisorycommittee/blood-tissue-safetyavailability/charter/.
Dated: October 22, 2020.
James J. Berger,
DFO, Advisory Committee on Blood and
Safety and Availability, Office of Infectious
Disease and HIV/AIDS Policy.
[FR Doc. 2020–24404 Filed 11–3–20; 8:45 am]
BILLING CODE 4150–28–P
VerDate Sep<11>2014
18:16 Nov 03, 2020
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Appointment to the Tick-Borne
Disease Working Group; Extension of
Nomination Period
Office of Infectious Disease and
HIV/AIDS Policy (OIDP), Office of the
Assistant Secretary for Health (OASH),
Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice; extension of nomination
period.
AGENCY:
The Office of the Assistant
Secretary for Health published a
document in the Federal Register on
October 6, 2020 seeking nominations of
non-federal public individuals who
represent diverse scientific disciplines
and views and are interested in being
considered for appointment to the TickBorne Disease Working Group
(TBDWG). Due to requests to extend the
nomination period, this document is
announcing a 30-day extension. The
October 6 notice can be accessed at
https://www.govinfo.gov/content/pkg/
FR-2020-10-06/pdf/2020-22062.pdf.
DATES: To be assured consideration,
nominations must be sent to the
TBDWG email address at
tickbornedisease@hhs.gov no later than
5:00 p.m. Eastern Standard Time on
December 5, 2020.
FOR FURTHER INFORMATION CONTACT: Mr.
James Berger, (202) 795–7608;
tickbornedisease@hhs.gov.
SUMMARY:
Dated: October 29, 2020.
James Berger,
Senior Advisor for Blood and Tissue Policy,
Designated Federal Officer, HHS Tick-Borne
Disease Working Group and the Advisory
Committee on Blood and Tissue Safety and
Availability, Office of the Assistant Secretary
for Health.
[FR Doc. 2020–24414 Filed 11–3–20; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Neurological Disorders and Stroke
Council.
The meeting will be open to the
public as indicated below. Individuals
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
70185
who plan to participate and need
special assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: February 3–4, 2021.
Open: February 03, 2021, 1:00 p.m. to 6:00
p.m.
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Activities; and Administrative
and Program Developments.
Open session will be videocast from this
link: https://videocast.nih.gov/.
Closed: February 04, 2021, 1:00 p.m. to
5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, NSC
Building, 6001 Executive Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Robert Finkelstein, Ph.D.,
Director of Extramural Research, National
Institute of Neurological Disorders and
Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248, finkelsr@ninds.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: October 29, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–24395 Filed 11–3–20; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\04NON1.SGM
04NON1
]]>Agencies
[Federal Register Volume 85, Number 214 (Wednesday, November 4, 2020)]
[Notices]
[Page 70185]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-24414]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Appointment to the Tick-Borne
Disease Working Group; Extension of Nomination Period
AGENCY: Office of Infectious Disease and HIV/AIDS Policy (OIDP), Office
of the Assistant Secretary for Health (OASH), Office of the Secretary,
Department of Health and Human Services.
ACTION: Notice; extension of nomination period.
-----------------------------------------------------------------------
SUMMARY: The Office of the Assistant Secretary for Health published a
document in the Federal Register on October 6, 2020 seeking nominations
of non-federal public individuals who represent diverse scientific
disciplines and views and are interested in being considered for
appointment to the Tick-Borne Disease Working Group (TBDWG). Due to
requests to extend the nomination period, this document is announcing a
30-day extension. The October 6 notice can be accessed at https://www.govinfo.gov/content/pkg/FR-2020-10-06/pdf/2020-22062.pdf.
DATES: To be assured consideration, nominations must be sent to the
TBDWG email address at [email protected] no later than 5:00 p.m.
Eastern Standard Time on December 5, 2020.
FOR FURTHER INFORMATION CONTACT: Mr. James Berger, (202) 795-7608;
[email protected].
Dated: October 29, 2020.
James Berger,
Senior Advisor for Blood and Tissue Policy, Designated Federal Officer,
HHS Tick-Borne Disease Working Group and the Advisory Committee on
Blood and Tissue Safety and Availability, Office of the Assistant
Secretary for Health.
[FR Doc. 2020-24414 Filed 11-3-20; 8:45 am]
BILLING CODE 4150-28-P
